NCT03762772View on ClinicalTrials.gov

Safety, PK, and PD Study of a Vaginal Insert Containing TAF and EVG

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

December 10, 2018

Primary Completion Date

March 20, 2019

Study Completion Date

March 20, 2019

Conditions
HivHSV
Interventions
DRUG

TAF/EVG Vaginal Insert

1 combination vaginal insert (20mg TAF/16mg EVG)

Trial Locations (1)

23507

Clinical Research Center at Eastern Virginia Medical School (NOT RECRUITING ADDITIONAL SITES), Norfolk

All Listed Sponsors
collaborator

Eastern Virginia Medical School

OTHER

collaborator

United States Agency for International Development (USAID)

FED

lead

CONRAD

OTHER

NCT03762772 - Safety, PK, and PD Study of a Vaginal Insert Containing TAF and EVG | Biotech Hunter | Biotech Hunter